SCHEMBL16685697

SCHEMBL16685697

Brc1ccc(C#CC2CC2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.45
CYP1A2 P05177 1/20 0.45
PTGES2 Q9H7Z7 1/20 0.33
OGA O60502 1/20 0.33
ALDH1A1 P00352 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MCHR1 Q99705 1/20 0.32
CHRNB2 P17787 2/20 0.31
CHRNA2 Q15822 2/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
DDB1 Q16531 1/20 0.31
CRBN Q96SW2 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15324177 0.78 GRM5 (0.45) GRM5CYP1A2PTGES2OGACHRNB2
SCHEMBL18810068 0.74 GRM5 (0.41) GRM5CYP1A2PTGES2OGAALDH1A1
SCHEMBL15991273 0.72 ADRA2A (0.38) GRM5ALDH1A1KDM4EMCHR1ADRA2A
SCHEMBL8575385 0.72 CHRNA7 (0.33) MCHR1
SCHEMBL15322866 0.71 MAPT (0.43) GRM5CYP1A2ALDH1A1ADRA2AADRA2B
SCHEMBL18478408 0.71 CYP1A2 (0.41) GRM5CYP1A2OGACHRNB2CHRNA2
SCHEMBL9855343 0.71 CHRNB2 (0.38) GRM5CYP1A2OGAALDH1A1CHRNB2
SCHEMBL9855339 0.71 CHRNB2 (0.38) GRM5CYP1A2OGAALDH1A1CHRNB2
SCHEMBL21258035 0.70 FFAR1 (0.47) GRM5CYP1A2
SCHEMBL9855115 0.69 CHRNB2 (0.40) GRM5CYP1A2OGACHRNB2CHRNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015066413-A1 OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS NOVARTIS AG (CH) 2015-05-07 WO disclosed